Epcoritamab + Rituximab & Lenalidomide vs Chemoimmunotherapy in FL

A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma

Disease Types: Lymphoma

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma 

For More Information:

https://clinicaltrials.gov/study/NCT06191744?term=Epcoritamab%20%2B%20Rituximab%20and%20Lenalidomide%20(R2)%20compared%20to%20Chemoimmunotherapy%20in%20Previously%20Untreated%20Follicular%20Lymphoma%20&rank=1